Showing results (471-480 of 650) with videos related to
Sort By:
Pageof 65
Nature Cancer|May 1, 2026
Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trialIgnacio Melero, Bernhard Reis, Corinne Rusterholz, et al.Nature Cancer|April 28, 2026
Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancerChengyi Li, Fang Ke, Hongyi Zhao, et al.Nature Cancer|March 26, 2026
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphomaFelix Czernilofsky, Anna Mathioudaki, Lea Jopp-Saile, et al.Nature Cancer|April 3, 2026
Single-cell and spatial profiling in cancer biology and clinical oncologyChris J Frangieh, Joy Linyue Fan, Johannes C Melms, et al.Nature Cancer|April 22, 2026
DeepFAN, a transformer-based model for human-artificial intelligence collaborative assessment of incidental pulmonary nodules in CT scans: a multireader, multicase trialZhenchen Zhu, Ge Hu, Weixiong Tan, et al.Nature Cancer|May 25, 2026
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trialKimberly J Perez, Andressa Dias Costa, Alexander Jordan, et al.Nature Cancer|May 20, 2026
Coupling dead cell recognition to Fcγ receptors augments anticancer immunityTomás Castro-Dopico, Cécile Piot, Michael D Buck, et al.Nature Cancer|May 12, 2026
Harnessing myeloid cell plasticity for cancer therapyEmilio Sanseviero, Simon T Barry, Dmitry I GabrilovichNature Cancer|June 10, 2026
Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypesDarui Jin, Artem Shmatko, Areeba Patel, et al.Nature Cancer|June 10, 2026
Iron-mediated ferroptosis impairs CAR-T cell function and antitumor efficacyDelin Kong, Tingting Yang, Mengyu Zhao, et al.Pageof 65